Mercantepe, F. Et Al. 2023. Histopathological evaluation of the effects of dexmedetomidine against pituitary damage induced by X-ray irradiation. BIOMARKERS , vol.28, no.2 , 168-176.

Mercantepe, F., Tümkaya, L., Mercantepe, T., & Rakıcı, S., (2023). Histopathological evaluation of the effects of dexmedetomidine against pituitary damage induced by X-ray irradiation. BIOMARKERS , vol.28, no.2, 168-176.

Mercantepe, Filiz Et Al. "Histopathological evaluation of the effects of dexmedetomidine against pituitary damage induced by X-ray irradiation," BIOMARKERS , vol.28, no.2, 168-176, 2023

Mercantepe, Filiz Et Al. "Histopathological evaluation of the effects of dexmedetomidine against pituitary damage induced by X-ray irradiation." BIOMARKERS , vol.28, no.2, pp.168-176, 2023

Mercantepe, F. Et Al. (2023) . "Histopathological evaluation of the effects of dexmedetomidine against pituitary damage induced by X-ray irradiation." BIOMARKERS , vol.28, no.2, pp.168-176.

@article{article, author={Filiz Mercantepe Et Al. }, title={Histopathological evaluation of the effects of dexmedetomidine against pituitary damage induced by X-ray irradiation}, journal={BIOMARKERS}, year=2023, pages={168-176} }